Actionable news
All posts from Actionable news
Actionable news in GILD: Gilead Sciences, Inc.,

PDUFA date today for Gilead's single-tablet HIV med Genvoya

Today is the FDA's action date for its review of Gilead Sciences' (GILD -2.5%) next-generation single tablet regimen for HIV-1 infection in adults, Genvoya (elvitegravir 150 mg/cobicistat 150...